Nórsko -
nórčina -
Statens legemiddelverk
zolpidem dune 10 mg
dune medicare aps - zolpidemtartrat - tablett, filmdrasjert - 10 mg
Nórsko -
nórčina -
Statens legemiddelverk
zolpidem dune 5 mg
dune medicare aps - zolpidemtartrat - tablett, filmdrasjert - 5 mg
Európska únia -
nórčina -
EMA (European Medicines Agency)
mepact
takeda france sas - mifamurtide - osteosarkom - immunostimulants, - mepact er indisert hos barn, ungdom og unge for behandling av høyverdig resektabel ikke-metastatisk osteosarkom etter makroskopisk fullstendig kirurgisk reseksjon. det brukes i kombinasjon med postoperativ multi-agent kjemoterapi. sikkerhet og effekt har blitt vurdert i studier av pasienter fra 2 til 30 år ved første diagnose.
Nórsko -
nórčina -
Statens legemiddelverk
vesikur 5 mg
orifarm as - solifenacinsuksinat - tablett, filmdrasjert - 5 mg
Nórsko -
nórčina -
Statens legemiddelverk
vesikur 10 mg
orifarm as - solifenacinsuksinat - tablett, filmdrasjert - 10 mg
Nórsko -
nórčina -
Statens legemiddelverk
rekovelle 72 mikrog/2.16 ml
2care4 aps - follitropin delta - injeksjonsvæske, oppløsning - 72 mikrog/2.16 ml
Európska únia -
nórčina -
EMA (European Medicines Agency)
adcetris
takeda pharma a/s - brentuximab vedotin - lymphoma, non-hodgkin; hodgkin disease - antineoplastiske midler - hodgkin lymphomaadcetris is indicated for adult patients with previously untreated cd30+ stage iv hodgkin lymphoma (hl) in combination with doxorubicin, vinblastine and dacarbazine (avd). adcetris is indicated for the treatment of adult patients with cd30+ hl at increased risk of relapse or progression following autologous stem cell transplant (asct). adcetris is indicated for the treatment of adult patients with relapsed or refractory cd30+ hodgkin lymphoma (hl):following asct, orfollowing at least two prior therapies when asct or multi-agent chemotherapy is not a treatment option. systemic anaplastic large cell lymphomaadcetris in combination with cyclophosphamide, doxorubicin and prednisone (chp) is indicated for adult patients with previously untreated systemic anaplastic large cell lymphoma (salcl). adcetris is indicated for the treatment of adult patients with relapsed or refractory salcl. cutaneous t cell lymphomaadcetris is indicated for the treatment of adult patients with cd30+ cutaneous t cell lymphoma (ctcl) after at least 1 prior systemic therapy.